The Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction In Preclinical Non-diabetic Chronic Kidney Disease

被引：0
|
作者：
Posada, Ixchel Lima
Stephan, Yohan
Soulie, Matthieu
Palacios-Ramirez, Roberto
Bonnard, Benjamin
Kolkhof, Peter
Mulder, Paul
Jaisser, Frederic
机构：
来源：
HYPERTENSION | 2023年 / 80卷
关键词：
Chronic kidney disease; Cardiorenal; Aldosterone;
D O I：
10.1161/hyp.80.suppl_1.080
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A080
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The non-steroidal mineralocorticoid receptor antagonist finerenone improves left ventricular function in preclinical chronic kidney disease
    Stephan, Y.
    Lima-Posada, I.
    Souille, M.
    Bonnard, B.
    Palacios, R.
    Nicol, L.
    Kolkhof, P.
    Jaisser, F.
    Mulder, P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2933 - 2933
  • [2] Finerenone - are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1253 - 1256
  • [3] Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease
    Verma, Ashish
    Patel, Ankit B.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (05): : 261 - 263
  • [4] Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease
    Lima Posada, Ixchel
    Soulie, Matthieu
    Stephan, Yohan
    Palacios Ramirez, Roberto
    Bonnard, Benjamin
    Nicol, Lionel
    Pitt, Bertram
    Kolkhof, Peter
    Mulder, Paul
    Jaisser, Frederic
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12): : e032971
  • [5] The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease
    Barrera-Chimal, Jonatan
    Gerarduzzi, Casimiro
    Rossignol, Patrick
    Jaisser, Frederic
    CLINICAL SCIENCE, 2022, 136 (12) : 1005 - 1017
  • [6] Effects of Non-Steroidal Mineralocorticoid Antagonist (Finerenone) in Western Diet-Induced Kidney Disease
    Myakala, Komuraiah
    Ribeiro, Patricia de Carvalho
    Wang, Xiaoxin
    Korolowicz, Kyle E.
    Rodriguez, Olga C.
    Albanese, Chris
    Levi, Moshe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 668 - 668
  • [7] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
    Lavall, D.
    Jacobs, N.
    Mahfoud, F.
    Kolkhof, P.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3326 - 3326
  • [8] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling
    Lavall, Daniel
    Jacobs, Nadine
    Mahfoud, Felix
    Kolkhof, Peter
    Boehm, Michael
    Laufs, Ulrich
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 173 - 183
  • [9] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Beavers, Craig J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (12) : 1785 - 1790
  • [10] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Craig J. Beavers
    Current Cardiology Reports, 2022, 24 : 1785 - 1790
12345